GILEAD SCIENCES, INC. Net Change in Cash 2007-2026 | GILD
Beta
What is net change in cash?
Net change in cash represents the total increase or decrease in cash and cash equivalents during the reporting period.
What is GILEAD SCIENCES, INC.'s current net change in cash?
GILEAD SCIENCES, INC. (GILD) annual net change in cash for 2025 was $-2.43B, a 162.16% decline from 2024. GILEAD SCIENCES, INC. net change in cash for the quarter ending March 31, 2026 was $65.0M.
What was GILEAD SCIENCES, INC.'s net change in cash in 2024?
GILEAD SCIENCES, INC. annual net change in cash for 2024 was $3.91B, a 480.39% increase from 2023.
What was GILEAD SCIENCES, INC.'s net change in cash in 2023?
GILEAD SCIENCES, INC. annual net change in cash for 2023 was $673.0M, a 809.46% increase from 2022.
Net Change in Cash History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-5.63B
→
FY2025
$-2.43B
07080910111213141516171819202122232425
5 years selected
Net Change in Cash History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-2.43B | -162.2% | 10-K |
| FY2024 | $3.91B | +480.4% | 10-K |
| FY2023 | $673.0M | +809.5% | 10-K |
| FY2022 | $74.0M | +111.2% | 10-K |
| FY2021 | $-659.0M | +88.3% | 10-K |
| FY2020 | $-5.63B | +10.7% | 10-K |
| FY2019 | $-6.31B | -160.9% | 10-K |
| FY2018 | $10.35B | +1715.0% | 10-K |
| FY2017 | $-641.0M | +86.1% | 10-K |
| FY2016 | $-4.62B | -263.7% | 10-K |
| FY2015 | $2.82B | -64.3% | 10-K |
| FY2014 | $7.91B | +2461.2% | 10-K |
| FY2013 | $309.0M | +103.8% | 10-K |
| FY2012 | $-8.08B | -190.0% | 10-K |
| FY2011 | $8.98B | +2558.6% | 10-K |
| FY2010 | $-365.1M | -95.9% | 10-K |
| FY2009 | $-186.3M | -137.9% | 10-K |
| FY2008 | $491.2M | +223.0% | 10-K |
| FY2007 | $152.1M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →